UniSa - IRIS Institutional Research Information System

MAGLIO, ANGELANTONIO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
AS - Asia 4.933
NA - Nord America 1.483
EU - Europa 829
SA - Sud America 156
AF - Africa 36
OC - Oceania 8
Continente sconosciuto - Info sul continente non disponibili 1
Totale 7.446
Salva come PNG Salva come JPEG
Nazione #
HK - Hong Kong 3.995
US - Stati Uniti d'America 1.432
IT - Italia 460
SG - Singapore 442
CN - Cina 151
VN - Vietnam 132
BR - Brasile 114
RU - Federazione Russa 109
DE - Germania 53
BD - Bangladesh 52
FR - Francia 49
IN - India 46
IE - Irlanda 32
MX - Messico 21
CA - Canada 18
GB - Regno Unito 18
KR - Corea 18
TR - Turchia 17
AR - Argentina 16
FI - Finlandia 15
ES - Italia 14
IQ - Iraq 14
JP - Giappone 14
NL - Olanda 14
ZA - Sudafrica 14
PL - Polonia 12
UA - Ucraina 12
CO - Colombia 10
SE - Svezia 9
AT - Austria 7
AU - Australia 7
ID - Indonesia 6
PK - Pakistan 6
CR - Costa Rica 5
EG - Egitto 5
SA - Arabia Saudita 5
CZ - Repubblica Ceca 4
EC - Ecuador 4
PH - Filippine 4
UZ - Uzbekistan 4
VE - Venezuela 4
AZ - Azerbaigian 3
BG - Bulgaria 3
DZ - Algeria 3
GR - Grecia 3
GY - Guiana 3
IL - Israele 3
JM - Giamaica 3
KE - Kenya 3
KW - Kuwait 3
LT - Lituania 3
MY - Malesia 3
NP - Nepal 3
TN - Tunisia 3
TT - Trinidad e Tobago 3
TW - Taiwan 3
AE - Emirati Arabi Uniti 2
BE - Belgio 2
ET - Etiopia 2
KG - Kirghizistan 2
LB - Libano 2
MA - Marocco 2
PE - Perù 2
PY - Paraguay 2
RO - Romania 2
SK - Slovacchia (Repubblica Slovacca) 2
AO - Angola 1
BO - Bolivia 1
BY - Bielorussia 1
CG - Congo 1
CH - Svizzera 1
CI - Costa d'Avorio 1
EE - Estonia 1
EU - Europa 1
LK - Sri Lanka 1
LY - Libia 1
MT - Malta 1
NI - Nicaragua 1
NO - Norvegia 1
NZ - Nuova Zelanda 1
OM - Oman 1
SI - Slovenia 1
YE - Yemen 1
Totale 7.446
Salva come PNG Salva come JPEG
Città #
Hong Kong 3.991
San Jose 257
Singapore 242
Ashburn 151
Milan 141
Chandler 127
Dallas 99
Ann Arbor 70
Council Bluffs 61
Beijing 59
Princeton 57
Naples 56
Lauterbourg 41
Rome 37
Los Angeles 36
New York 34
Ho Chi Minh City 31
Dublin 29
Munich 29
Hanoi 27
Moscow 25
Santa Clara 25
Woodbridge 24
The Dalles 21
Jacksonville 18
Dong Ket 17
Salerno 17
Pune 15
Pollena Trocchia 14
Frankfurt am Main 13
Izmir 12
São Paulo 12
Chicago 11
Mexico City 11
Tokyo 11
Warsaw 11
Boardman 10
Boston 10
Da Nang 10
Johannesburg 10
Memphis 10
Montreal 10
Atlanta 9
Baghdad 9
Denver 9
Orem 9
Turku 9
Brooklyn 8
Buffalo 8
Houston 8
Seattle 8
Turin 8
Wilmington 8
Chennai 7
San Francisco 7
Acerra 6
Campobasso 6
Dearborn 6
Haiphong 6
New Delhi 6
Amsterdam 5
Andover 5
Avellino 5
Bologna 5
London 5
Mumbai 5
Nuremberg 5
Phoenix 5
Redwood City 5
Rio de Janeiro 5
Sarno 5
Stockholm 5
Bari 4
Brasília 4
Castellammare di Stabia 4
Charlotte 4
Figino 4
Grammichele 4
Nanjing 4
Ninh Bình 4
Poplar 4
San José 4
Sydney 4
Toronto 4
Trani 4
Verona 4
Vienna 4
Birmingham 3
Brno 3
Curitiba 3
Dhaka 3
Florence 3
Foggia 3
Georgetown 3
Helsinki 3
Kathmandu 3
Kuwait City 3
Nairobi 3
Osio Sotto 3
Querétaro 3
Totale 6.188
Salva come PNG Salva come JPEG
Nome #
Combination of Ruxolitinib and Eculizumab for Treatment of Severe SARS-CoV-2-Related Acute Respiratory Distress Syndrome: A Controlled Study 893
Sustained remission induced by 2 years of treatment with benralizumab in patients with severe eosinophilic asthma and nasal polyposis 699
Long-Term Clinical and Sustained REMIssion in Severe Eosinophilic Asthma Treated With Mepolizumab: The REMI-M Study 594
Eosinophilic inflammation: An Appealing Target for Pharmacologic Treatments in Severe Asthma 570
Effects of inhaled beclomethasone dipropionate/formoterol fumarate/glycopyrronium on diaphragmatic workload and lung function in uncontrolled asthma: a case report 484
Acute Coronary Syndrome in patients with SARS-CoV-2 infection: Pathophysiology and Translational Perspectives 456
Phenotyping severe asthma: a rationale for biologic therapy 430
Novel Biological Therapies for Severe Asthma Endotypes 244
Pharmacotherapeutic strategies for critical asthma syndrome: a look at the state of the art 204
Age as a risk factor in the occurrence of pneumothorax after transthoracic fine needle biopsy: our experience 179
Long-term treatment in pediatric asthma: an update on chemical pharmacotherapy 163
SIRT1 Activity in Peripheral Blood Mononuclear Cells Correlates with Altered Lung Function in Patients with Chronic Obstructive Pulmonary Disease 133
Post-COVID-19 Syndrome: Involvement and Interactions between Respiratory, Cardiovascular and Nervous Systems 129
Activation of the AIM2 Receptor in Circulating Cells of Post-COVID-19 Patients With Signs of Lung Fibrosis Is Associated With the Release of IL-1α, IFN-α and TGF-β 128
Diagnostic yield and safety of C-TBNA in elderly patients with lung cancer. 123
Effectiveness of Benralizumab in OCS-Dependent Severe Asthma: The Impact of 2 Years of Therapy in a Real-Life Setting 113
Chronic obstructive pulmonary disease and heart failure: Common diseases of the elderly, frequent non-recognition and the value of specialist referral 110
Real-Life Clinical and Functional Effects of Fluticasone Furoate/Umeclidinium/Vilanterol-Combined Triple Therapy in Patients with Chronic Obstructive Pulmonary Disease 109
Tezepelumab: A potential new biological therapy for severe refractory asthma 103
Severe Asthma Remissions Induced by Biologics Targeting IL5/IL5r: Results from a Multicenter Real-Life Study 93
Effect of the Arg16Gly β2-Adrenergic Receptor Polymorphism on Long-Term Mepolizumab Response and Clinical Remission in Severe Eosinophilic Asthma: A Genotype-Stratified, Multicenter Study 89
Biological Therapy of Severe Asthma with Dupilumab, a Dual Receptor Antagonist of Interleukins 4 and 13 89
Cluster Analysis Identifies Patients With Severe Eosinophilic Asthma Who Achieve Super-Response and Remission With Mepolizumab 89
Real-life effectiveness of mepolizumab on forced expiratory flow between 25% and 75% of forced vital capacity in patients with severe eosinophilic asthma 88
Post-COVID-19 Patients Who Develop Lung Fibrotic-like Changes Have Lower Circulating Levels of IFN-β but Higher Levels of IL-1α and TGF-β 87
DPO: DIFFUSE PULMONARY OSSIFICATION - A DIAGNOSTIC CHALLENGE 84
Olfactory and gustatory function impairment in COVID-19 patients: Italian objective multicenter-study 81
Compendio di malattie dell'apparato respiratorio 78
Interleukins 4 and 13 in Asthma: Key Pathophysiologic Cytokines and Druggable Molecular Targets 73
Achieving sustained remission in severe asthma: goals, challenges, issues and opportunities 70
Small airways function: evaluation in a population of adult patients with severe asthma and potential use as a response biomarker for anti-IL5 therapy 64
Prevalence of Persistent Olfactory Disorders in Patients With COVID-19: A Psychophysical Case-Control Study With 1-Year Follow-up 64
Design per una nuova cultura della prevenzione 61
Clinical and Functional Effects of Inhaled Dual Therapy Umeclidinium/Vilanterol in Patients with Chronic Obstructive Pulmonary Disease: A Real-Life Study 59
Benralizumab in Patients with Severe Eosinophilic Asthma: A Multicentre Real-Life Experience 59
THE MANY FACES OF COVID-19: ORGANIZING PNEUMONIA (OP) PATTERN HRCT FEATURES 55
Mindfulness-Based Interventions for Chronic Pulmonary Diseases: A Systematic Review of Effects on Anxiety, Depression, Stress, Dyspnea, and Quality of Life 48
Key role of thymic stromal lymphopoietin as a molecular target for biologic treatment of severe asthma 46
Pathobiology of Type 2 Inflammation in Asthma and Nasal Polyposis 38
Effects of Pulmonary Rehabilitation on Dyspnea, Quality of Life and Cognitive Function in COPD: A Systematic Review 37
Biologic Therapy in Severe Asthma: A Phenotype-Driven and Targeted Approach 29
Real-World Efficacy of Beclomethasone Dipropionate/Formoterol Fumarate/Glycopyrronium on Diaphragmatic Workload Assessed by Ultrasound and Lung Function in Patients with Uncontrolled Asthma 26
Real-life effects of dupilumab in patients with severe type 2 asthma, according to atopic trait and presence of chronic rhinosinusitis with nasal polyps 26
Arg16Gly 132-Adrenoreceptor Polymorphism in Severe EosinophilicAsthma: Implications for Mepolizumab Long-Term Effectiveness and Clinical Remission 25
SIRT 1 and oxidative stress in COPD pathogenesis 25
Difficult-To-Treat and Severe Asthma: Can Real-World Studies On Effectiveness of Biological Treatments Change the Lives of Patients? 25
Obesity and respiratory function impairment in asthmatic and non asthmatic children 22
Effects of Tezepelumab in “United Airway Disease” (Asthma and CRSwNP) 13
Assessing response to biological therapies in severe asthma 7
Predictive Factors And Treatments Associated with Clinical Remission in Severe Eosinophilic Asthma 6
Totale 7.520
Salva come PNG Salva come JPEG
Categoria #
all - tutte 18.783
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 18.783
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022108 0 0 3 1 0 7 12 3 10 5 21 46
2022/2023290 18 40 26 38 22 51 8 26 25 6 20 10
2023/2024215 16 15 9 12 6 41 11 40 4 13 9 39
2024/2025534 7 8 10 24 18 56 130 21 70 31 62 97
2025/20266.064 963 1.996 1.277 171 282 130 329 78 212 253 115 258
2026/202745 45 0 0 0 0 0 0 0 0 0 0 0
Totale 7.520